GAITIANLI GAITIANLI

  • HOME

  • ABOUT US

    • Company Profile

    • Honor

    • Public welfare undertakings

  • NEWS & INFORMATION

    • Company News

    • Frontiers of Medicine

    • Product Information

  • PRODUCTS

    • Huaier Granules

    • Huaiqihuang (HQH) Granule

    • Functional Characteristics

    • Overview of Ongoing Research Projects

  • RESEARCH MATERIALS

    • Huaier Granules

    • Huaiqihuang (HQH) Granule

    • Member Download

    • Public Information

  • CONTACT

中文版

English

新闻资讯

Company News

Medical Frontiers

Product Information

  • Home
Huaier Granules, Huaiqi Yellow Granules Product Logo-Copyright Certificate

Huaier Granules, Huaiqi Yellow Granules Product Logo-Copyright Certificate

13

2020

/

08

Notifications

Notifications

27

2020

/

07

Interpretation of the latest version of the "liver cancer diagnosis and treatment norms", the anti-cancer effect of traditional Chinese medicine has been approved by foreign scholars!

Interpretation of the latest version of the "liver cancer diagnosis and treatment norms", the anti-cancer effect of traditional Chinese medicine has been approved by foreign scholars!

14

2020

/

04

Letter on Doing a Good Job in Linking New and Old Charity Assistance Models of Huaier Granules

Letter on Doing a Good Job in Linking New and Old Charity Assistance Models of Huaier Granules

Dear Jiangsu, Shandong, Hunan, Chongqing and other four patients: On October 8, 2019, the China Charity Federation and Qidong Gaitianli Pharmaceutical Co., Ltd. signed the "Huaier Granule Patient Assistance Project Cooperation Agreement".

14

2020

/

03

Warmly congratulate Huaier Granule on its re-inclusion in the 2019 edition of "Standard for Diagnosis and Treatment of Primary Liver Cancer"-Level 1 evidence shows that Huaier Granule treatment after hepatectomy can reduce recurrence and prolong survival.

Warmly congratulate Huaier Granule on its re-inclusion in the 2019 edition of "Standard for Diagnosis and Treatment of Primary Liver Cancer"-Level 1 evidence shows that Huaier Granule treatment after hepatectomy can reduce recurrence and prolong survival.

On December 7, at the 17th National Conference on Liver Cancer, the National Health Commission officially released the "Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2019 Edition)".

07

2019

/

12

Huaiqihuang Granules for the Treatment of CKD3 Primary Glomerulonephritis Initiated Meeting Held in Dalian

Huaiqihuang Granules for the Treatment of CKD3 Primary Glomerulonephritis Initiated Meeting Held in Dalian

On the morning of December 7, 2019, the first affiliated Hospital of Dalian Medical University sponsored the "randomized double-blind double-simulation, positive parallel controlled multicenter clinical study of Huaiqihuang Granules in the treatment of CKD3 primary glomerulonephritis" held in Shangri-La Hotel, Dalian, which is the highest level of evidence-based medicine for Huaiqihuang Granules in the treatment of primary glomerulonephritis.

07

2019

/

12

The launching ceremony of "Huaier Granules Patient Assistance Project" was held in Taiyuan. Gong Puguang, vice chairman of the Social Construction Committee of the 13th National people's Congress and president of the China Charity Federation, delivered a speech and announced the launch of the project.

The launching ceremony of "Huaier Granules Patient Assistance Project" was held in Taiyuan. Gong Puguang, vice chairman of the Social Construction Committee of the 13th National people's Congress and president of the China Charity Federation, delivered a speech and announced the launch of the project.

On November 12, the launching ceremony of "Huaier granule patient assistance project" of China Charity Federation was held in Taiyuan City, Shanxi Province. Gong Puguang, vice chairman of the Social Construction Committee of the 13th National people's Congress and president of the China Charity Federation, Xu Wuwei, chairman and general manager of Qidong Gaitianli Pharmaceutical Co., Ltd., and Bian Zhiwei, secretary general of the China Charity Federation, attended the launching ceremony.

12

2019

/

11

Heavy! Treatment of bronchial asthma in children have a new choice!

Heavy! Treatment of bronchial asthma in children have a new choice!

At the 28th National Academic Forum on Childhood Asthma and Allergy Diseases held on April 20, 2019, Professor Liu Chuanhe from the Children's Hospital of the Capital Institute of Pediatrics discussed the real-world research on the effectiveness of Huaiqihuang Granules in the treatment of childhood bronchial asthma. The statistical results were grandly released.

23

2019

/

04

< 123456 >
Assistance projects
GAITIANLI

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Address

1166 West Nanyuan Road, Qidong Economic Development Zone, Jiangsu Province

Telephone

0086-513-83101860 / 0086-513-83321533

E-mail

yonghu@gaitianli.com.cn

  • HOME

  • ABOUT US

    • Company Profile

    • Honor

    • Public welfare undertakings

  • NEWS & INFORMATION

    • Company News

    • Frontiers of Medicine

    • Product Information

  • PRODUCTS

    • Huaier Granules

    • Huaiqihuang (HQH) Granule

    • Functional Characteristics

    • Overview of Ongoing Research Projects

  • RESEARCH MATERIALS

    • Huaier Granules

    • Huaiqihuang (HQH) Granule

    • Member Download

    • Public Information

  • CONTACT

Mobile website

Mobile website

Public Number

Public Number

Copyright © 2024 Qidong Gaitianli Pharmaceutical Co., Ltd.

Business License

Powered by 300.CN | Label